You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NKTR Award Disclosure
Zalevsky Jonathan · SEC Form 4 · Filed Jul 24, 2026
Award
Calculated transaction value
$0
Zalevsky Jonathan Chief R&D Officer
NKTR
Nektar Therapeutics
NKTR
Transaction date
Jul 24, 2026
Public filing date
Jul 24, 2026
Filing lag
Filed same day
NKTR daily price context
Close on/before transaction
$70.72
Jul 24, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 16,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-316458
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nektar Therapeutics NKTR Current | Award | Jul 24, 2026 | $0 |